Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
170.1 USD | +1.32% | +4.61% | +9.72% |
06:14pm | US CDC warns of harmful reactions to fake Botox injections | RE |
Apr. 22 | Pfizer: new Emblaveo antibiotic approved in the EU | CF |
Financials (USD)
Sales 2024 * | 54.57B | Sales 2025 * | 57.78B | Capitalization | 297B |
---|---|---|---|---|---|
Net income 2024 * | 9.08B | Net income 2025 * | 11.09B | EV / Sales 2024 * | 6.43 x |
Net Debt 2024 * | 53.67B | Net Debt 2025 * | 45.01B | EV / Sales 2025 * | 5.92 x |
P/E ratio 2024 * |
30.3
x | P/E ratio 2025 * |
24.9
x | Employees | 50,000 |
Yield 2024 * |
3.72% | Yield 2025 * |
3.88% | Free-Float | 96.75% |
Latest transcript on AbbVie Inc.
1 day | +1.45% | ||
1 week | +4.61% | ||
Current month | -6.63% | ||
1 month | -4.76% | ||
3 months | +1.51% | ||
6 months | +17.48% | ||
Current year | +9.72% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Gonzalez
CEO | Chief Executive Officer | 70 | 12-12-31 |
Scott Reents
DFI | Director of Finance/CFO | 57 | 12-12-31 |
Robert Michael
PSD | President | 53 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 63 | 12-12-31 |
Edward Rapp
BRD | Director/Board Member | 66 | 12-12-31 |
Director/Board Member | 70 | 12-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.12% | 6 M€ | 0.00% | - | |
6.85% | 18 M€ | +2.56% | - | |
6.26% | 13 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 170.1 | +1.30% | 2 031 653 |
24-04-22 | 167.9 | +0.89% | 5,580,685 |
24-04-19 | 166.4 | +1.06% | 5,532,492 |
24-04-18 | 164.7 | +0.25% | 4,480,224 |
24-04-17 | 164.2 | +1.05% | 4,792,382 |
Delayed Quote Nyse, April 23, 2024 at 12:26 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.72% | 297B | |
+27.41% | 659B | |
+27.68% | 557B | |
-4.27% | 359B | |
+16.61% | 322B | |
+6.30% | 215B | |
+4.80% | 210B | |
-6.05% | 200B | |
-8.79% | 149B | |
-4.95% | 146B |
- Stock Market
- Equities
- ABBV Stock